Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ovarian Neoplasms

  Free Subscription


01.05.2017

1 Am J Surg Pathol
1 BMC Cancer
2 Histopathology
3 Hum Pathol
3 Int J Gynaecol Obstet
6 Int J Gynecol Pathol
1 J Clin Oncol
2 Lancet Oncol
2 Oncol Rep
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg Pathol

  1. RAMBAU PF, McIntyre JB, Taylor J, Lee S, et al
    Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
    Am J Surg Pathol. 2017 Jan 25. doi: 10.1097/PAS.0000000000000812.
    PubMed     Text format     Abstract available


    BMC Cancer

  2. LIU Y, Chen S, Zheng C, Ding M, et al
    The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
    BMC Cancer. 2017;17:285.
    PubMed     Text format     Abstract available


    Histopathology

  3. HOANG LN, Lee YS, Karnezis AN, Tessier-Cloutier B, et al
    Immunophenotypic features of dedifferentiated endometrial carcinoma - insights from BRG1/INI1-deficient tumours.
    Histopathology. 2016;69:560-9.
    PubMed     Text format     Abstract available

  4. SNIR OL, Buza N, Hui P
    Mucinous epithelial tumours arising from ovarian mature teratomas: a tissue genotyping study.
    Histopathology. 2016;69:383-92.
    PubMed     Text format     Abstract available


    Hum Pathol

  5. ROSSI ED, Bizzarro T, Monterossi G, Inzani F, et al
    Clinicopathological analysis of mixed endometrial carcinomas: clinical relevance of different neoplastic components.
    Hum Pathol. 2016 Dec 29. pii: S0046-8177(16)30357.
    PubMed     Text format     Abstract available

  6. HAREL-DASSA K, Yedgar S, Trope CG, Davidson B, et al
    Phospholipase D messenger RNA expression and clinical role in high-grade serous carcinoma.
    Hum Pathol. 2017;62:115-121.
    PubMed     Text format     Abstract available

  7. PELLETIER MP, Trinh VQ, Stephenson P, Mes-Masson AM, et al
    Microcystic, elongated and fragmented (MELF) pattern invasion is mainly associated with isolated tumor cell pattern metastases in FIGO grade I endometrioid endometrial cancer (EEC).
    Hum Pathol. 2016 Nov 15. pii: S0046-8177(16)30306.
    PubMed     Text format     Abstract available


    Int J Gynaecol Obstet

  8. PARK JY, Suh DS, Kim JH, Kim YM, et al
    Outcomes of fertility-sparing surgery among young women with FIGO stage I clear cell carcinoma of the ovary.
    Int J Gynaecol Obstet. 2016 Mar 11. pii: S0020-7292(16)30006.
    PubMed     Text format     Abstract available

  9. KIM ML, Cho YJ, Kim MK, Jung YW, et al
    The efficacy of long-term maintenance therapy with a levonorgestrel-releasing intrauterine system for prevention of ovarian endometrioma recurrence.
    Int J Gynaecol Obstet. 2016 Jun 4. pii: S0020-7292(16)30164.
    PubMed     Text format     Abstract available

  10. LIAN C, Chen X, Ni Y, Huang X, et al
    Pregnancy after fertility-sparing surgery for borderline ovarian tumors.
    Int J Gynaecol Obstet. 2016 Jun 3. pii: S0020-7292(16)30165.
    PubMed     Text format     Abstract available


    Int J Gynecol Pathol

  11. SANGOI AR, Kshirsagar M, Horvai AE, Roma AA, et al
    SATB2 Expression Is Sensitive but Not Specific for Osteosarcomatous Components of Gynecologic Tract Carcinosarcomas: A Clinicopathologic Study of 60 Cases.
    Int J Gynecol Pathol. 2017;36:140-145.
    PubMed     Text format     Abstract available

  12. CHOUGULE A, Dey P
    Hilus Cell Heterotopia With Intraneural Eutopia.
    Int J Gynecol Pathol. 2017;36:200-202.
    PubMed     Text format    

  13. HJORTKJAER M, Waldstrom M, Jakobsen A, Kanstrup H, et al
    The Prognostic Value of BRCA1 and PARP Expression in Epithelial Ovarian Carcinoma: Immunohistochemical Detection.
    Int J Gynecol Pathol. 2017;36:180-189.
    PubMed     Text format     Abstract available

  14. NEWTON CL, Brockbank E, Singh N, Faruqi A, et al
    A Case of Stage 4B Seromucinous Ovarian Borderline Tumor With Endometriosis and Review of the Literature.
    Int J Gynecol Pathol. 2017;36:195-199.
    PubMed     Text format     Abstract available

  15. SAID I, Bohm S, Beasley J, Ellery P, et al
    The Chemotherapy Response Score (CRS): Interobserver Reproducibility in a Simple and Prognostically Relevant System for Reporting the Histologic Response to Neoadjuvant Chemotherapy in Tuboovarian High-grade Serous Carcinoma.
    Int J Gynecol Pathol. 2017;36:172-179.
    PubMed     Text format     Abstract available

  16. CHEN W, Husain A, Nelson GS, Rambau PF, et al
    Immunohistochemical Profiling of Endometrial Serous Carcinoma.
    Int J Gynecol Pathol. 2017;36:128-139.
    PubMed     Text format     Abstract available


    J Clin Oncol

  17. BERCHUCK A, Havrilesky LJ, Kauff ND
    Is There a Role for Ovarian Cancer Screening in High-Risk Women?
    J Clin Oncol. 2017;35:1384-1386.
    PubMed     Text format    


    Lancet Oncol

  18. HARTER P
    A new standard of care or just another option for patients with relapsed ovarian cancer?
    Lancet Oncol. 2017 Apr 21. pii: S1470-2045(17)30253.
    PubMed     Text format    

  19. COLEMAN RL, Brady MF, Herzog TJ, Sabbatini P, et al
    Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial.
    Lancet Oncol. 2017 Apr 21. pii: S1470-2045(17)30279.
    PubMed     Text format     Abstract available


    Oncol Rep

  20. NAKAMURA K, Terai Y, Tanabe A, Ono YJ, et al
    CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways.
    Oncol Rep. 2017 Apr 19. doi: 10.3892/or.2017.5583.
    PubMed     Text format     Abstract available

  21. LIU Y, Li H, Ban Z, Nai M, et al
    Annexin A2 inhibition suppresses ovarian cancer progression via regulating beta-catenin/EMT.
    Oncol Rep. 2017 Apr 18. doi: 10.3892/or.2017.5578.
    PubMed     Text format     Abstract available


    PLoS One

  22. COZZI GD, Levinson RT, Toole H, Snyder MR, et al
    Blood type, ABO genetic variants, and ovarian cancer survival.
    PLoS One. 2017;12:e0175119.
    PubMed     Text format     Abstract available

  23. BRENCICOVA E, Jagger AL, Evans HG, Georgouli M, et al
    Interleukin-10 and prostaglandin E2 have complementary but distinct suppressive effects on Toll-like receptor-mediated dendritic cell activation in ovarian carcinoma.
    PLoS One. 2017;12:e0175712.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: